ENDRA Life Sciences Inc

NDRA · NASDAQ · Healthcare / Diagnostics & Research

4.41USD-0.23 (-4.96%)

Price History

Full chart

Market Stats

Previous Close4.64

Open4.51

Day Range4.41 – 4.52

52-Week Range2.96 – 9.85

Volume4.55K

Market Cap9.06M

P/E (TTM)0.00

Forward P/E0.00

EPS-6.29

Dividend Yield0.00%

Beta-0.04

50-Day Avg5.11

200-Day Avg4.76

About

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Company Details

SectorHealthcare
IndustryDiagnostics & Research
CEOMr. Alexander Y. Tokman
Employees9
Headquarters3600 Green Court, Ann Arbor, MI, United States, 48105-1570, USA
Websitehttps://endrainc.com

Leadership

Mr. Alexander Y. TokmanCEO & Chairman · b. 1962
Mr. Richard JacrouxCFO & Secretary · b. 1968
Dr. Jonathan Behr Ph.D.Co-Founder
Mr. Scott SoberHead of Operations
Mr. Ziad Rouag J.D.Head of Regulatory & Clinical Affairs
Mr. Idan SteinbergHead of Engineering

Financials

Income Statement

Currency: USD	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	559.36K	1.41M	515.58K	351.62K	6.17K	0	0	0	0	0	0	0
Growth (%)	-	+152.09%	-63.44%	-31.80%	-98.24%	-100.00%	-	-	-	-	-	-
Cost of Revenue	259.14K	666.23K	235.88K	172.78K	0	115.01K	165.25K	224.41K	234.26K	275.45K	206.17K	-
Gross Profit	300.21K	743.83K	279.70K	178.84K	6.17K	-115.01K	-165.25K	-224.41K	-234.26K	-275.45K	-206.17K	-
Gross Margin	53.67%	52.75%	54.25%	50.86%	100.00%	-	-	-	-	-	-	-
Operating Expense	1.83M	2.31M	2.07M	4.80M	9.03M	10.73M	11.34M	11.27M	12.92M	10.25M	10.61M	-
Operating Income	-1.53M	-1.57M	-1.79M	-4.63M	-9.02M	-10.84M	-11.50M	-11.50M	-13.16M	-10.52M	-10.82M	-5.76M
Operating Margin	-272.85%	-111.24%	-347.52%	-1315.63%	-146080.47%	-	-	-	-	-	-	-
EBITDA	-1.49M	-1.50M	-1.73M	-4.56M	-9.00M	-10.84M	-11.33M	-11.01M	-12.92M	-9.78M	-11.30M	-6.87M
EBITDA Margin	-266.19%	-106.12%	-334.93%	-1298.15%	-145751.60%	-	-	-	-	-	-	-
Net Income	-2.18M	-2.28M	-2.78M	-5.38M	-9.80M	-13.31M	-11.73M	-11.23M	-13.18M	-10.06M	-11.51M	-7.03M
Net Income Margin	-389.89%	-161.64%	-538.30%	-1529.19%	-158669.60%	-	-	-	-	-	-	-
R&D	873.17K	1.04M	495.38K	1.93M	4.72M	6.57M	5.92M	5.48M	6.55M	5.00M	3.19M	1.85M
R&D as % of Total Revenue	156.10%	73.68%	96.08%	549.19%	76489.55%	-	-	-	-	-	-	-
Interest Expense	0	0	0	0	729.24K	2.36M	232.43K	267.06K	21.53K	-	-	-
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	11811.48%	-	-	-	-	-	-	-

Balance Sheet

Currency: USD	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	702.93K	486.72K	490.76K	6.12M	7.22M	7.18M	8.76M	12.87M	9.27M	6.75M	4.45M	3.85M
Total Liabilities	97.60K	236.42K	1.38M	848.21K	974.58K	2.42M	1.60M	2.09M	2.07M	1.10M	1.89M	1.59M
Total Equity	605.33K	250.30K	-893.77K	5.28M	6.25M	4.76M	7.17M	10.78M	7.20M	5.66M	2.56M	2.26M
Cash	156.44K	19.13K	144.95K	5.60M	6.47M	6.17M	7.23M	9.46M	4.89M	2.83M	3.23M	762.37K
Total Debt	-	-	949.98K	-	22.51	773.27K	769.34K	796.09K	546.63K	394.40K	754.14K	492.35K
Net Debt	-156.44K	-19.13K	805.02K	-5.60M	-6.47M	-5.40M	-6.46M	-8.67M	-4.34M	-2.44M	-2.48M	-270.01K

Cash Flow

Currency: USD	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-1.40M	-842.73K	-1.32M	-3.30M	-7.70M	-8.59M	-10.77M	-11.12M	-12.77M	-9.55M	-7.40M	-5.18M
Investing Cash Flow	-275.37K	-133.81K	-7.86K	-7.86K	-100.00K	-43.59K	-75.33K	-45.00K	-202.58K	-24.72K	-12.80K	-3.02M
Financing Cash Flow	1.75M	839.22K	1.44M	8.77M	8.67M	8.34M	11.88M	13.40M	8.40M	7.52M	7.81M	5.73M
Capital Expenditure	275.37K	133.81K	7.86K	7.86K	100.00K	43.59K	51.33K	45.00K	202.58K	33.88K	16.00K	17.28K
Free Cash Flow	-1.67M	-976.54K	-1.32M	-3.31M	-7.80M	-8.63M	-10.82M	-11.17M	-12.97M	-9.58M	-7.42M	-5.20M
Dividends Paid	-	-	-	-	-	4.22M	395.55K	121.07K	7.79K	840	5.23K	-
FCF to OCF	119.71%	115.88%	100.00%	100.24%	101.30%	100.51%	100.48%	100.40%	101.59%	100.35%	100.22%	100.33%
Dividend Paid to FCF	-	-	-	-	-	-48.88%	-3.66%	-1.08%	-0.06%	-0.01%	-0.07%	-

Earnings

Report Date	Jun 21, 2017	Aug 7, 2017	Nov 14, 2017	Mar 20, 2018	May 15, 2018	Aug 13, 2018	Nov 5, 2018	Mar 11, 2019	May 14, 2019	Aug 8, 2019	Nov 13, 2019	Mar 26, 2020	May 14, 2020	Aug 14, 2020	Nov 16, 2020	Mar 25, 2021	May 17, 2021	Aug 12, 2021	Nov 15, 2021	Mar 30, 2022	May 12, 2022	Aug 15, 2022	Nov 14, 2022	Mar 14, 2023	May 15, 2023	Aug 14, 2023	Nov 14, 2023	Mar 28, 2024	May 14, 2024	Aug 14, 2024	Nov 15, 2024	Mar 31, 2025	May 15, 2025	Aug 14, 2025	Nov 14, 2025	Dec 31, 2025	May 15, 2026	Aug 14, 2026	Nov 13, 2026
EPS Estimate	0.00	-	-	-	-	-	-	-	-10500.01	-10850.01	-11900.01	-5.75	-11725.01	-9450.01	-6066.67	-2.90	-2625.00	-2450.00	-2800.00	-1.60	-2800.00	-1925.00	-1925.00	-0.90	-1828.75	-962.50	-752.50	-0.36	-472.50	-122.50	-62.30	-4.10	-3.91	-2.27	-1.95	-1.23	-1.23	-0.84	-0.84
EPS Actual	-0.19	-0.59	-0.23	-0.58	-0.72	-0.47	-0.70	-0.37	-12950.01	-10850.01	-16100.02	-24.00	-10150.01	-7000.01	-5250.01	-2.00	-2100.00	-2800.00	-2100.00	-1.60	-2450.00	-2100.00	-1750.00	-0.96	-1627.50	-752.50	-700.00	-0.05	-455.00	-140.00	-9.54	25.20	-2.59	-1.71	-2.10	-2.23	-1.09	-0.63	-
Surprise	-	-	-	-	-	-	-	-	-23.33%	0.00%	-35.29%	-317.39%	13.43%	25.93%	13.46%	31.03%	20.00%	-14.29%	25.00%	0.00%	12.50%	-9.09%	9.09%	-6.67%	11.00%	21.82%	6.98%	86.11%	3.70%	-14.29%	84.69%	714.63%	33.76%	24.67%	-7.69%	-81.68%	11.38%	25.00%	-
Timing	-	-	-	-	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	-	After-hours	After-hours	-	After-hours	After-hours	-

Key Statistics & Ratios

Market Cap9.06M

Enterprise Value8.47M

Trailing P/E0.00

Forward P/E0.00

PEG Ratio0.00

Price / Sales1838.78

Price / Book1.55

EPS-6.29

Book Value4.21

Revenue (TTM)0

Gross Profit (TTM)0

EBITDA-6.61M

Profit Margin0.00%

Operating Margin0.00%

Return on Equity-152.04%

Return on Assets-77.32%

Shares Outstanding1.50M

Shares Float1.43M

Beta-0.04

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Strong Buy

Based on 1 analystsTarget 25.00

Strong Buy
1

Ownership Breakdown

Institutions: 17.98%
Insiders: 12.39%
Retail / Other: 69.63%

Top Institutional Holders

Altium Capital Management, LP
59.27K3.95%
Citadel Advisors Llc
29.92K2.00%
Citizens Financial Group Inc
28.40K1.89%
Geode Capital Management, LLC
21.08K1.41%
Vanguard Fiduciary Trust Co
10.12K0.67%
Morgan Stanley - Brokerage Accounts
3.55K0.24%
Vanguard Capital Management, LLC
2.82K0.19%
UBS Group AG
1520.01%
Northwestern Mutual Wealth Management Co
190.00%
Caitong International Asset Management Co., Limited.
40.00%
Citigroup Inc
00.00%
Bank of America Corp
00.00%

Top Fund Holders

Fidelity Extended Market Index
6.58K0.49%
Fidelity Nasdaq Composite Index
2.98K0.22%
Fidelity Series Total Market Index
1.60K0.12%

Stock Splits

Nov 7, 20241:35
Aug 20, 20241:50
Dec 9, 20221:20